FR3116273B1 - Tétrapeptides, compositions les comprenant et leur utilisation cosmétique - Google Patents

Tétrapeptides, compositions les comprenant et leur utilisation cosmétique Download PDF

Info

Publication number
FR3116273B1
FR3116273B1 FR2011742A FR2011742A FR3116273B1 FR 3116273 B1 FR3116273 B1 FR 3116273B1 FR 2011742 A FR2011742 A FR 2011742A FR 2011742 A FR2011742 A FR 2011742A FR 3116273 B1 FR3116273 B1 FR 3116273B1
Authority
FR
France
Prior art keywords
chosen
xaa
tetrapeptides
skin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2011742A
Other languages
English (en)
Other versions
FR3116273A1 (fr
Inventor
Philippe Mondon
Olivier Peschard
Richard Leroux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Priority to FR2011742A priority Critical patent/FR3116273B1/fr
Priority to CN202180077315.4A priority patent/CN116615176A/zh
Priority to EP21810355.4A priority patent/EP4247835A1/fr
Priority to PCT/EP2021/081723 priority patent/WO2022106365A1/fr
Priority to KR1020237020301A priority patent/KR20230110549A/ko
Priority to US18/035,860 priority patent/US20230399359A1/en
Publication of FR3116273A1 publication Critical patent/FR3116273A1/fr
Application granted granted Critical
Publication of FR3116273B1 publication Critical patent/FR3116273B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Tétrapeptides, compositions les comprenant et leur utilisation cosmétique Tétrapeptide de formule X-(Xaa)nPG(Xaa)m-Z dans laquelle Xaa est un acide aminé choisi parmi A et V, les Xaa étant choisis indépendamment les uns des autres, soit n=2 et m=0, soit n=1 et m=1, avec en extrémité N-terminale X choisi parmi H, -CO-R1, -SO2-R1 ou un groupe biotinoyle ; en extrémité C-terminale Z choisi parmi OH, OR1, NH2, NHR1 ou NR1R2 ; et R1 et R2 étant, indépendamment l’un de l’autre, choisis parmi un groupe alkyle, aryle, aralkyle, alkylaryl, alkoxy, saccharide et aryloxy, pouvant être linéaire, ramifié, cyclique, polycyclique, insaturé, hydroxylé, carbonylé, phosphorylé et/ou soufré, ledit groupe ayant de 1 à 24 atomes de carbone et pouvant posséder dans son squelette un ou plusieurs hétéroatomes O, S et/ou N. Les séquences peptidiques préférées sont X-AVPG-Z et X-VPGA-Z.Ces tétrapeptides stimulent la synthèse des molécules constituant la matrice extracellulaire dermique, notamment le collagène 1 et 4 et la fibronectine, et peuvent être utilisés pour un traitement cosmétique notamment anti-âge, anti-rides et ridules, pour améliorer les propriétés mécaniques de la peau, fermeté/tonicité/élasticité/souplesse, pour augmenter la densité et le volume de la peau, pour un effet restructurant et/ou pour lutter contre les vergétures, et/ou pour lutter contre l’affaissement cutané.
FR2011742A 2020-11-17 2020-11-17 Tétrapeptides, compositions les comprenant et leur utilisation cosmétique Active FR3116273B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR2011742A FR3116273B1 (fr) 2020-11-17 2020-11-17 Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
CN202180077315.4A CN116615176A (zh) 2020-11-17 2021-11-15 四肽、包含其的组合物及其美容用途
EP21810355.4A EP4247835A1 (fr) 2020-11-17 2021-11-15 Tétrapeptides, compositions les comprenant, et leur utilisation cosmétique
PCT/EP2021/081723 WO2022106365A1 (fr) 2020-11-17 2021-11-15 Tétrapeptides, compositions les comprenant, et leur utilisation cosmétique
KR1020237020301A KR20230110549A (ko) 2020-11-17 2021-11-15 테트라펩타이드, 이를 포함하는 조성물, 및 이의 화장품 용도
US18/035,860 US20230399359A1 (en) 2020-11-17 2021-11-15 Tetrapeptides, compositions comprising them, and their cosmetic use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2011742 2020-11-17
FR2011742A FR3116273B1 (fr) 2020-11-17 2020-11-17 Tétrapeptides, compositions les comprenant et leur utilisation cosmétique

Publications (2)

Publication Number Publication Date
FR3116273A1 FR3116273A1 (fr) 2022-05-20
FR3116273B1 true FR3116273B1 (fr) 2023-10-27

Family

ID=74045915

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2011742A Active FR3116273B1 (fr) 2020-11-17 2020-11-17 Tétrapeptides, compositions les comprenant et leur utilisation cosmétique

Country Status (6)

Country Link
US (1) US20230399359A1 (fr)
EP (1) EP4247835A1 (fr)
KR (1) KR20230110549A (fr)
CN (1) CN116615176A (fr)
FR (1) FR3116273B1 (fr)
WO (1) WO2022106365A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3136172A1 (fr) * 2022-06-07 2023-12-08 L V M H Recherche Composition anti-âge avec extraits de rose et peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
AU2001275018B2 (en) * 2000-05-30 2008-04-03 Connective Tissue Imagineering Llc Composition and method for enhancing elasticity of tissue
US6794362B1 (en) * 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
US8318678B2 (en) * 2008-05-30 2012-11-27 Jan Marini Skin Research Cosmetic compositions
EP2623097B1 (fr) * 2012-02-01 2015-07-15 Samsung Electronics Co., Ltd Nanoparticules lipidiques solides comprenant des polypeptides semblables à de l'élastine et son utilisation
FR2998570B1 (fr) 2012-11-26 2016-12-02 Sederma Sa Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
FR3021319B1 (fr) 2014-05-22 2018-08-31 Sederma Peptides, compositions les comprenant et utilisations notamment cosmetiques
FR3029782B1 (fr) 2014-12-16 2019-06-07 Sederma Composes peptidiques, compositions les comprenant et utilisations notamment cosmetiques
FR3052453B1 (fr) 2016-06-14 2018-05-18 Sederma Peptide, composition le comprenant et utilisations notamment cosmetiques

Also Published As

Publication number Publication date
EP4247835A1 (fr) 2023-09-27
WO2022106365A1 (fr) 2022-05-27
US20230399359A1 (en) 2023-12-14
KR20230110549A (ko) 2023-07-24
CN116615176A (zh) 2023-08-18
FR3116273A1 (fr) 2022-05-20

Similar Documents

Publication Publication Date Title
CN106999401B (zh) 肽化合物、包含它们的组合物和所述化合物,特别是化妆品的用途
EP2037942B1 (fr) Biotensioactifs polymériques
FR3052453A1 (fr) Peptide, composition le comprenant et utilisations notamment cosmetiques
KR101093685B1 (ko) 신규한 팔미토일트리펩타이드와 이를 함유하는 주름개선 화장품 조성물
WO2009148947A1 (fr) Agents tensioactifs biologiques oligomères dans des compositions dermato-cosmétiques
FR3021319A1 (fr) Peptides, compositions les comprenant et utilisations notamment cosmetiques
EP2049562A1 (fr) Peptides ayant une activité pharmacologique pour le traitement de troubles associés à la migration de cellules altérées, tels que le cancer
FR3116273B1 (fr) Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
CN101384274B (zh) 包含具有非天然存在的氨基酸的肽的组合物及其使用方法
EP2271667B1 (fr) Collagène issu de corail
KR101224519B1 (ko) 피부노화방지 및 피부주름개선용 상황버섯 균사체 발효콜라겐을 함유하는 피부노화방지 및 피부주름개선선용 화장료 조성물
FR3116275B1 (fr) Tétrapeptide, composition le comprenant et son utilisation cosmétique
FR3116274B1 (fr) Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
KR20210113604A (ko) 화장품에서 사용하기 위한 펩타이드 및 조성물
CN109730943A (zh) 一种祛皱组合物
CN109152757A (zh) N-硫辛酸-氨基酸或肽、衍生物以及它们的用途
CN102498128A (zh) 具有转化生长因子的活性的肽及其用途
CN115350113A (zh) 一种含胜肽的组合物及其应用
KR101822633B1 (ko) 폴리스타틴 유래 생리활성 펩타이드, 및 이의 용도
AU2017399481B2 (en) Conjugate of salicylic acid and peptide
EP1458748B1 (fr) Peptides ayant un effet sur l'apoptose
FR3112941B1 (fr) Traitement cosmétique ou dermatologique à base de peptide(s) de la peau et de ses phanères
KR20180108990A (ko) 펩타이드를 활용한 피부의 노화 억제용 조성물 및 세포노화 억제와 주름개선을 위한 화장품 조성물
KR20180108984A (ko) 콜라겐 생성을 촉진시키는 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부 노화 방지를 위한 화장품 조성물
KR20210150839A (ko) 팔미토일트리펩타이드 화합물을 함유하는 피부개선에 효과적인 화장품 조성물

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20220520

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4